Results 151 to 160 of about 11,291,129 (270)

Clinical Outcomes of Colorectal Endoscopic Full‐Thickness Resection Using the Full‐Thickness Resection Device: A Multicenter Study

DEN Open, Volume 7, Issue 1, April 2027.
ABSTRACT Background Endoscopic full‐thickness resection (EFTR) using the full‐thickness resection device (FTRD) is an emerging technique for the management of complex colorectal lesions and early colorectal cancers. Although EFTR offers a minimally invasive alternative to surgery, data on efficacy, safety, and predictors of adverse events (AEs) remain ...
Vicki McGarrigle, Yuto Shimamura, Leonardo Zorron Cheng Tao Pu, Marios Efthymiou, Rhys Vaughan, Cameron Schauer, Anurag Sekra, Erin Horsfall, Alexandra Simpson, Rajvinder Singh, Nicholas Wan, Milan Bassan, Martin Harb, Ben Terkasher, Frank Weilert, Saurabh Gupta, Kwang Chien Yee, Rajan Patel, Ibrahim Hassan, Byron Theron, Sujievvan Chandran   +20 more
wiley   +1 more source

AL Amyloidosis [PDF]

, 2020
openaire   +3 more sources

Comparative Evaluation of Hemodiafiltration, Hemoperfusion, and Standard Hemodialysis on Efficacy, Inflammatory Control, Dialysis Adequacy, and Safety in End‐Stage Renal Disease: A Prospective Observational Study

Therapeutic Apheresis and Dialysis, Volume 30, Issue 6, Page 880-892, December 2026.
ABSTRACT Background Chronic micro‐inflammation in patients with end‐stage renal disease (ESRD) is a significant driver of cardiovascular complications and diminished quality of life. While standard hemodialysis (SHD) effectively manages small‐molecule clearance, its ability to remove medium‐to‐large uremic toxins—the primary catalysts of systemic ...
Hongwei Zuo, Weisi Dai, Jie Mao, Mei Ye, Xingshan Lu, Xiaocui Zhang   +5 more
wiley   +1 more source

The light chain hunt: appraising assays in AL amyloidosis. [PDF]

Blood Adv
Staron A.
europepmc   +1 more source

Giant abdominal hematoma from injection into an insulin ball during dual antithrombotic and corticosteroid therapy

Journal of Diabetes Investigation, EarlyView.
Yasuhiro Tanji, Hiroshi Komamura, Takashi Mita, Shojiro Sawada   +3 more
wiley   +1 more source

Can Spleen T1 Mapping Be Used as a Marker of Adenosine Response in Cardiac MRI?

NMR in Biomedicine, Volume 39, Issue 12, December 2026.
Patients with suspected coronary artery disease were scanned at 1.5 T with the routine clinical protocol for CMR. T1 mapping sequence at rest and during stress was included in which the spleen was visible. Splenic switch‐off was visually assessed in first‐pass images.
Sergio M. Solis‐Barquero, Ana Ezponda, Verónica Aramendía‐Vidaurreta, Marta Vidorreta, Marina Pascual, Gorka Bastarrika, Maria A. Fernández‐Seara   +6 more
wiley   +1 more source

Management of relapsed/refractory AL amyloidosis. [PDF]

Blood Adv
Ling J, Sidiqi MH, Gertz M.
europepmc   +1 more source

An Atypical Skin Presentation of Adult‐Onset Still's Disease With Histological Description: A Case Report

Journal of Cutaneous Pathology, Volume 53, Issue 12, Page 1080-1084, December 2026.
ABSTRACT Adult‐onset Still's disease (AOSD) is an auto inflammatory disorder with a variable clinical presentation, and without a pathognomonic diagnostic test, characterized by high spiking fever, arthralgia/arthritis, a suggestive skin rash, elevated white blood cell count 10 G/L (> 80% neutrophils), elevated ferritin, with glycosylated ferritin < 20%
M. Nordmann, T. Mazza, S. Menzinger, G. Kaya, S. Bogiatzi, S. Vandenberghe‐Dürr, M. Blanchard, J. Stirnemann   +7 more
wiley   +1 more source

Daratumumab monotherapy for relapsed AL amyloidosis: a single center retrospective analysis. [PDF]

Blood Res
Yi JH, Yoon SE, Kim SJ, Kim D, Choi JO, Min JH, Kim BJ, Kim JS, Lee JE, Jeon J, Choi JY, Kim K.   +11 more
europepmc   +1 more source

Memory Services for People With Down Syndrome: A Scoping Review Exploring Models of Care and Access

Journal of Policy and Practice in Intellectual Disabilities, Volume 23, Issue 4, December 2026.
ABSTRACT More than 95% of people with Down syndrome develop Alzheimer's disease (AD), with a median age of diagnosis of approximately 54 years. However, there is a significant gap in guidance regarding the design of effective memory services and tailored diagnostic pathways.
M. Healy, A. Brodtmann, A. M. Foster, D. Ayton   +3 more
wiley   +1 more source